Article
Transthyretin Amyloid Cardiomyopathy–2025 Update: Current Diagnostic Approaches and Emerging Therapeutic Options
2025-05-26
Abstract excerpt
Transthyretin‐related (ATTR) amyloidosis is a progressive and life‐threatening disease caused by the systemic accumulation of amyloid fibril deposits composed of misfolded transthyretin (TTR) monomers. Clinical manifestations are highly heterogeneous, including symptoms of cardiomyopathy and/or polyneuropathy, depending on the composition and location of fibril deposits. Although ATTR amyloidosis is considered a r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a7987491-8222-5586-8b60-2f1d5994da70
- DOI
- 10.20944/preprints202505.2056.v1
